Abstract
Objective—To study the effects on myocardial ischaemia of 50 mg of atenolol, 20 mg of slow release nifedipine, and their fixed combination given 12 hourly.
Design—A treadmill exercise test and 24 hour ambulatory electrocardiographic monitoring were carried out after a period of five days off treatment (control) and at the end of three weeks of each treatment period.
Patients—23 patients with stable angina pectoris, documented coronary artery disease, and a positive exercise test were randomised in a double blind, three way, cross over study.
Results—Compared with the control, nifedipine significantly induced an increase in resting heart rate of (mean (SEM)) 14 (2) beats/min whereas atenolol and the combination significantly reduced it by 24 (2) and 20 (1) beats/min respectively. The number of exercise tests rendered negative after each intervention was five for nifedipine, nine for atenolol, and 11 for the combination. Compared with the control the time to the start of myocardial ischaemia (1 mm ST segment depression) during exercise significantly increased by 3·2 (0·6) min after nifedipine, by 4·6 (0·4) min after atenolol, and by 4·6 (0·5) min after the combination; rate-pressure product (beats/min. mm Hg) at 1 mm ST segment depression increased by 2824 (970) after nifedipine but fell by 4436 (900) and 4501 (719) after atenolol and the combination. The weekly frequency of angina was reduced from a mean of five while taking nifedipine, to three while taking atenolol, and to two while taking the combination. The total ischaemic time during ambulatory monitoring was significantly reduced from 69 (17) min during control to 37·5 (9·8) min during nifedipine, to 15·6 (5·5) min during atenolol, and to 6·5 (2·7) min during the combination.
Conclusion—The undesirable effect of a high basal heart rate induced by nifedipine was neutralised by its combination with atenolol. Whereas atenolol and the combination were equally efficacious in controlling exercise induced ischaemia, the combination was more effective in reducing total ischaemic burden.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bache R. J., Tockman B. A. Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog. Circ Res. 1982 May;50(5):678–687. doi: 10.1161/01.res.50.5.678. [DOI] [PubMed] [Google Scholar]
- Cannon R. O., 3rd, Watson R. M., Rosing D. R., Epstein S. E. Angina caused by reduced vasodilator reserve of the small coronary arteries. J Am Coll Cardiol. 1983 Jun;1(6):1359–1373. doi: 10.1016/s0735-1097(83)80037-0. [DOI] [PubMed] [Google Scholar]
- Dargie H. J., Lynch P. G., Krikler D. M., Harris L., Krikler S. Nifedipine and propranolol: a beneficial drug interaction. Am J Med. 1981 Oct;71(4):676–682. doi: 10.1016/0002-9343(81)90238-2. [DOI] [PubMed] [Google Scholar]
- Ellis A. K., Klocke F. J. Effects of preload on the transmural distribution of perfusion and pressure-flow relationships in the canine coronary vascular bed. Circ Res. 1980 Jan;46(1):68–77. doi: 10.1161/01.res.46.1.68. [DOI] [PubMed] [Google Scholar]
- Epstein S. E., Talbot T. L. Dynamic coronary tone in precipitation, exacerbation and relief of angina pectoris. Am J Cardiol. 1981 Oct;48(4):797–803. doi: 10.1016/0002-9149(81)90160-0. [DOI] [PubMed] [Google Scholar]
- Findlay I. N., MacLeod K., Ford M., Gillen G., Elliott A. T., Dargie H. J. Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J. 1986 Mar;55(3):240–245. doi: 10.1136/hrt.55.3.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gage J. E., Hess O. M., Murakami T., Ritter M., Grimm J., Krayenbuehl H. P. Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation. 1986 May;73(5):865–876. doi: 10.1161/01.cir.73.5.865. [DOI] [PubMed] [Google Scholar]
- Gunther S., Green L., Muller J. E., Mudge G. H., Jr, Grossman W. Prevention of nifedipine of abnormal coronary vasoconstriction in patients with coronary artery disease. Circulation. 1981 Apr;63(4):849–855. doi: 10.1161/01.cir.63.4.849. [DOI] [PubMed] [Google Scholar]
- Lown B. Symposium on nifedipine and calcium flux inhibition in the treatment of coronary arterial spasm and myocardial ischemia. Introduction. Am J Cardiol. 1979 Oct 22;44(5):780–782. doi: 10.1016/0002-9149(79)90196-6. [DOI] [PubMed] [Google Scholar]
- Maseri A. Medical therapy of chronic stable angina pectoris. Circulation. 1990 Dec;82(6):2258–2262. doi: 10.1161/01.cir.82.6.2258. [DOI] [PubMed] [Google Scholar]
- Maseri A. The changing face of angina pectoris: practical implications. Lancet. 1983 Apr 2;1(8327):746–749. doi: 10.1016/s0140-6736(83)92035-4. [DOI] [PubMed] [Google Scholar]
- Schanzenbächer P., Liebau G., Deeg P., Kochsiek K. Effect of intravenous and intracoronary nifedipine on coronary blood flow and myocardial oxygen consumption. Am J Cardiol. 1983 Mar 1;51(5):712–717. doi: 10.1016/s0002-9149(83)80120-9. [DOI] [PubMed] [Google Scholar]
- Waxman H. L., Josephson M. E. Ventricular activation during ventricular endocardial pacing: I. Electrocardiographic patterns related to the site of pacing. Am J Cardiol. 1982 Jul;50(1):1–10. doi: 10.1016/0002-9149(82)90002-9. [DOI] [PubMed] [Google Scholar]